Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 111

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Sources and Physiological Significance of Plasma Dopamine Sulfate

Goldstein, David S., Swoboda, Kathryn J., Miles, John M., Coppack, Simon W., Aneman, Anders, Holmes, Courtney, Lamensdorf, Isaac, Eisenhofer, Graeme · 1999 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Dopamine in the circulation occurs mainly as dopamine sulfate, the sources and physiological significance of which have been obscure. In this study, plasma concentrations of dopamine sulfate were measured after a meal, after fasting for 4 days, and during i.v. L-DOPA, nitroprusside, or trimethaphan infusion in volunteers; after dopamine infusion in patients with L-aromatic-amino-acid decarboxylase deficiency; in arterial and portal venous plasma of gastrointestinal surgery patients; and in patients with sympathetic neurocirculatory failure. Meal ingestion increased plasma dopamine sulfate by more than 50-fold; however, prolonged fasting decreased plasma dopamine sulfate only slightly. L-DOPA infusion produced much larger increments in dopamine sulfate than in dopamine; the other drugs were without effect. Patients with L-aromatic amino acid decarboxylase deficiency had decreased dopamine sulfate levels, and patients with sympathetic neurocirculatory failure had normal levels. Decarboxylase-deficient patients undergoing dopamine infusion had a dopamine sulfate/dopamine ratio about 25 times less than that at baseline in volunteers. Surgery patients had large arterial-portal venous increments in plasma concentrations of dopamine sulfate, so that mesenteric dopamine sulfate production accounted for most of urinary dopamine sulfate excretion, a finding consistent with the localization of the dopamine sulfoconjugating enzyme to gastrointestinal tissues. The results indicate that plasma dopamine sulfate derives mainly from sulfoconjugation of dopamine synthesized from L-DOPA in the gastrointestinal tract. Both dietary and endogenous determinants affect plasma dopamine sulfate. The findings suggest an enzymatic gut-blood barrier for detoxifying exogenous dopamine and delimiting autocrine/paracrine effects of endogenous dopamine generated in a "third catecholamine system."

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.84.7.5864

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 55

  1. Kagedal, 1988, Catecholamines and their metabolites., J Chromatogr, 429, 177, 10.1016/S0378-4347(00)83871-2 · DOI · Paper page
  2. 1985, Catecholamine metabolism: basic aspects and clinical significance., Pharmacol Rev, 37, 333, 10.1016/S0031-6997(25)06859-0 · DOI · Paper page
  3. Lambert, 1991, Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity., Life Sci, 49, 1061, 10.1016/0024-3205(91)90593-Z · DOI
  4. Lambert, 1993, Regional homovanillic acid production in humans., Life Sci, 53, 63, 10.1016/0024-3205(93)90612-7 · DOI
  5. Kuchel, 1991, Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle., Hypertension, 18, 709, 10.1161/01.HYP.18.6.709 · DOI
  6. Kuchel, 1984, Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension., J Lab Clin Med, 104, 238
  7. Buu, 1979, The direct conversion of dopamine 3-O-sulfate to norepinephrine by dopamineβ -hydroxylase., Life Sci, 24, 783, 10.1016/0024-3205(79)90361-8 · DOI
  8. Eldrup, 1997, Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid., Clin Sci (Colch), 92, 423, 10.1042/cs0920423 · DOI
  9. Kuchel, 1982, Sulfoconjugation of catecholamines, nutrition, and hypertension, Hypertension., 4, III93, 10.1161/01.HYP.4.5_Pt_2.III93 · DOI
  10. Ratge, 1991, Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations., J Pharmacol Exp Ther, 257, 232, 10.1016/S0022-3565(25)24783-8 · doi:10.1016/s0022-3565(25)24783-8
  11. Jones, 1995, Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form., Biochem Biophys Res Commun, 208, 855, 10.1006/bbrc.1995.1414 · DOI
  12. Ratge, 1990, Dopamine infusion in healthy subjects and critically ill patients., Clin Exp Pharmacol Physiol, 17, 361, 10.1111/j.1440-1681.1990.tb01332.x · doi:10.1111/j.1440-1681.1990.tb01332.x
  13. Claustre, 1990, Conjugation and deamination of circulating dopamine: relationship between sulfated and free dopamine in man., J Auton Nerv Syst, 29, 175, 10.1016/0165-1838(90)90183-J · doi:10.1016/0165-1838(90)90183-j
  14. Goldstein, 1997, Sympathetic cardioneuropathy in dysautonomias., N Engl J Med, 336, 696, 10.1056/NEJM199703063361004 · DOI · Paper page
  15. Mezey, 1996, A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine., Proc Natl Acad Sci USA, 93, 10377, 10.1073/pnas.93.19.10377 · DOI
  16. Wolfovitz, 1993, Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans., Clin Sci (Colch), 84, 549, 10.1042/cs0840549 · DOI
  17. Goldstein, 1997, 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function–studies in normal humans., Clin Auton Res, 7, 17, 10.1007/BF02267622 · DOI
  18. Eisenhofer, 1996, Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans., J Neurochem, 66, 1565, 10.1046/j.1471-4159.1996.66041565.x · DOI · Paper page
  19. Eisenhofer, 1986, Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase., Clin Chem, 32, 2030, 10.1093/clinchem/32.11.2030 · DOI · Paper page
  20. Holmes, 1994, Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection., J Chromatogr B Biomed Appl, 653, 131, 10.1016/0378-4347(93)E0430-X · DOI · Paper page
  21. Goldstein, 1997, Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans., Clin Exp Hypertens, 19, 155, 10.3109/10641969709080812 · doi:10.3109/10641969709080812
  22. Rubin, 1996, Design, production and characterization of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase., Xenobiotica, 26, 1113, 10.3109/00498259609050256 · DOI
  23. Banwart, 1989, Plasma dopa and feeding., Proc Soc Exp Biol Med, 191, 357, 10.3181/00379727-191-42933 · DOI
  24. Hoeldtke, 1974, Cereal ingestion and catecholamine excretion., Metabolism, 23, 33, 10.1016/0026-0495(74)90101-2 · DOI
  25. Mezey, 1992, Localization of targets for anti-ulcer drugs in cells of the immune system Science, 258, 1662
  26. Yamamoto, 1996, Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure., J Lab Clin Med, 128, 488, 10.1016/S0022-2143(96)90045-1 · DOI
  27. Rea, 1990, Relation of plasma norepinephrine and sympathetic traffic during hypotension in man, Am J Physiol., 258, R982
  28. Ogaki, 1995, Plasma sulpho-conjugated catecholamine dynamics up to 8 h after 60-min exercise at 50% and 70% maximal oxygen uptakes., Eur J Appl Physiol, 72, 6, 10.1007/BF00964107 · DOI
  29. Bauer, 1989, Exercise training produces changes in free and conjugated catecholamines., Med Sci Sports Exerc, 21, 558, 10.1249/00005768-198910000-00010 · doi:10.1249/00005768-198910000-00010
  30. Kuchel, 1984, Regional sources of free and sulfoconjugated catecholamines in hypertension, Hypertension., 6, I51, 10.1161/01.HYP.6.2_Pt_2.I51 · doi:10.1161/01.hyp.6.2_pt_2.i51
  31. Elchisak, 1982, Method for analysis of dopamine sulfate isomers by high performance liquid chromatography., Life Sci, 30, 2325, 10.1016/0024-3205(82)90260-0 · DOI
  32. Coughtrie, 1998, Biology and function of the reversible sulfation pathway catalyzed by human sulfotransferases and sulfatases., Chem Biol Interact, 109, 3, 10.1016/S0009-2797(97)00117-8 · DOI · Paper page
  33. Tyce, 1987, Human liver and conjugation of catecholamines., J Lab Clin Med, 109, 532
  34. Goldstein, 1987, Neuronal source of plasma dihydroxyphenylalanine., J Clin Endocrinol Metab, 64, 856, 10.1210/jcem-64-4-856 · DOI
  35. Eisenhofer, 1989, Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans., J Clin Endocrinol Metab, 68, 247, 10.1210/jcem-68-2-247 · DOI
  36. Eisenhofer, 1992, Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs., Neurochem Int, 21, 37, 10.1016/0197-0186(92)90066-Z · DOI
  37. Meredith, 1991, Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure., Clin Auton Res, 1, 187, 10.1007/BF01824986 · DOI · Paper page
  38. Grossman, 1992, Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats., Clin Sci (Colch), 83, 65, 10.1042/cs0830065 · doi:10.1042/cs0830065
  39. Kvetnansky, 1992, Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation., J Pharmacol Exp Ther, 261, 899, 10.1016/S0022-3565(25)11162-2 · DOI
  40. Tyce, 1995, Effluxes of 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylglycol, and norepinephrine from four blood vessels during basal conditions and during nerve stimulation., J Neurochem, 64, 833, 10.1046/j.1471-4159.1995.64020833.x · DOI
  41. Davidson, 1981, Effects of eating bananas on plasma free and sulfate-conjugated catecholamines., Life Sci, 29, 1773, 10.1016/0024-3205(81)90187-9 · DOI
  42. Dunne, 1983, The effect of ascorbic acid on plasma sulfate conjugated catecholamines after eating bananas., Life Sci, 33, 1511, 10.1016/0024-3205(83)90855-X · doi:10.1016/0024-3205(83)90855-x
  43. 1940, Inactivation of adrenaline in vivo in man., J Physiol, 98, 361, 10.1113/jphysiol.1940.sp003854 · DOI · Paper page
  44. Ganguly, 1995, Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase., Drug Metab Dispos, 23, 945, 10.1016/S0090-9556(25)06733-9 · DOI
  45. Weinshilboum, 1994, Sulfation pharmacogenetics in humans., Chem Biol Interact, 92, 233, 10.1016/0009-2797(94)90066-3 · DOI
  46. Dooley, 1994, Genomic organization and DNA sequence of the human catecholamine-sulfating phenol sulfotransferase gene (STM)., Biochem Biophys Res Commun, 205, 482, 10.1006/bbrc.1994.2691 · doi:10.1006/bbrc.1994.2691
  47. Kuchel, 1981, Essential hypertension with low conjugated catecholamines imitates pheochromocytoma., Hypertension, 3, 347, 10.1161/01.HYP.3.3.347 · doi:10.1161/01.hyp.3.3.347
  48. Vieira-Coelho, 1993, Dopamine formation, from its immediate precursor 3,4-dihydroxyphenylalanine, along the rat digestive tract., Fundam Clin Pharmacol, 7, 235, 10.1111/j.1472-8206.1993.tb00237.x · DOI
  49. Finkel, 1994, Endogenous dopamine modulates jejunal sodium absorption during high-salt diet in young but not in adult rats., Gastroenterology, 107, 675, 10.1016/0016-5085(94)90114-7 · DOI
  50. Glavin, 1990, Dopamine in gastrointestinal disease., Dig Dis Sci, 35, 1153, 10.1007/BF01537589 · DOI
  51. 1979, Dopamine disorder in duodenal ulceration., Lancet, 2, 880
  52. Eldrup, 1995, CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson’s disease., Acta Neurol Scand, 92, 116, 10.1111/j.1600-0404.1995.tb01023.x · DOI
  53. Stoddard, 1989, Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients., Exp Neurol, 104, 218, 10.1016/0014-4886(89)90032-0 · doi:10.1016/0014-4886(89)90032-0
  54. Carmichael, 1988, Decreased catecholamines in the adrenal medulla of patients with parkinsonism., N Engl J Med, 318, 254, 10.1056/NEJM198801283180415 · doi:10.1056/nejm198801283180415
  55. 1979, Dopamine and duodenal ulcer., Lancet, 2, 1191

Cited by

See all 111

Metadata

Authors
Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., Lamensdorf, I., & Eisenhofer, G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1999-07-01
Volume
84
Issue
7
Pages
2523-2531
ISSN
  • 0021-972X
  • 1945-7197
Cited by
111
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sources and Physiological Significance of Plasma Dopamine Sulfate. https://app.cochat.ai/papers/10.1210/jcem.84.7.5864
The paper
Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., Lamensdorf, I., & Eisenhofer, G. (1999). Sources and Physiological Significance of Plasma Dopamine Sulfate. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.84.7.5864

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.